Ventilatory Strategy Based on Ultrasound Lung Morphology in Patients With Focal ARDS

NCT ID: NCT04966624

Last Updated: 2025-11-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

84 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-10-13

Study Completion Date

2028-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

ARDS is characterized by a diffuse, bilateral, extensive alveolar-interstitial infiltrate related to damage to the alveolar membrane.

Studies of lung morphology assessed by CT scan have shown 2 types of ARDS. When the loss of ventilation is posterior and caudal, and the pulmonary parenchyma is otherwise "healthy", ARDS is said to be focal. When the loss of ventilation is diffuse, associated with excess tissue affecting the entire lung parenchyma, ARDS is said to be non-focal or diffuse.

Only one recent multicenter study has evaluated whether individualized PEEP adjustment according to lung morphology (focal vs. non-focal) could improve ARDS survival outcomes compared with standard of care. Results for the primary endpoint, 90-day mortality, were negative. But lung morphology was misclassified on CT occurred 85 (21%) of 400 patients. In addition, per-protocol analysis in which misclassified patients were excluded showed that mortality was significantly lower in the personalized ventilation group than in the control group.

Lung ultrasound may be the ideal bedside imaging technique. The loss of pulmonary aeration and its variations induced by therapeutic maneuvers can be quantified by lung ultrasound. Lung ultrasound is a non-invasive, non-ionizing radiation method that can be easily used at the bedside.

APRV ventilation coupled with spontaneous breathing activity prevents atelectasis formation, recruits less ventilated areas, prevents mechanical ventilation-induced lung injury and improves lung compliance.

The hypothesis is that a "LUVS" ventilatory strategy composed of a bundle of measures all aiming at reopening the atelectatic pulmonary zones in focal ARDS (synergistic effect of spontaneous ventilation in APRV mode, early prone sessions, and adjustment of PEEP according to the patient's BMI), could decrease the number of days under mechanical ventilation, compared to protective ventilation with low tidal volume according to the current international recommendations

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Focal Acute Respiratory Distress Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

interventional

Group Type EXPERIMENTAL

LUVS" ventilatory strategy composed of a bundle of measures

Intervention Type PROCEDURE

Ventilation in APRV mode early prone sessions, adjustment of positive expiratory pressure according to the patient's BMI and no curarization

control

Group Type ACTIVE_COMPARATOR

Ventilatory management according to international recommendations (Société de Réanimation de la Langue Française)

Intervention Type PROCEDURE

Ventilatory management according to international recommendations (Société de Réanimation de la Langue Française)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LUVS" ventilatory strategy composed of a bundle of measures

Ventilation in APRV mode early prone sessions, adjustment of positive expiratory pressure according to the patient's BMI and no curarization

Intervention Type PROCEDURE

Ventilatory management according to international recommendations (Société de Réanimation de la Langue Française)

Ventilatory management according to international recommendations (Société de Réanimation de la Langue Française)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* person who has given oral consent or has been included in an emergency
* Older than 18 years
* On mechanical ventilation for less than 24 hours
* Diagnosis of ARDS for less than 24 hours. ARDS according to the Berlin classification: i.e. arterial oxygen pressure to inspired oxygen fraction ratio less than or equal to 300, with a PEEP greater than or equal to 5, presence of bilateral radiological infiltrates not fully explained by heart failure or volume overload
* Focal ARDS determined on pulmonary ultrasound

Exclusion Criteria

* person who is not a beneficiary of national health insurance
* person who is subject to a legal measure of protection (curatorship, guardianship)
* pregnant or breastfeeding women
* minor
* Patient having benefited from an invasive mechanical ventilation of more than one week in the previous month;
* ARDS in the previous month;
* Chronic respiratory failure under NIV or long term oxygen;
* Severe acute asthma;
* Lobectomy;
* Pneumothorax;
* Pneumomediastinum;
* Pulmonary fibrosis;
* Morbid obesity with a BMI above 40 ;
* Cancer with metastasis;
* Bone marrow transplantation;
* Chemotherapy-induced neutropenia;
* Cirrhosis with a Child-Pugh score of C;
* Suspected or confirmed intracranial hypertension;
* Concurrent participation in another ARDS study;
* Extensive burns on the torso.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire Dijon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chu Dijon Bourgogne

Dijon, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

BOUHEMAD Belaid

Role: CONTACT

03 80 29 30 79

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

ABAGRI Sohel

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BOUHEMAD Abagri 2021

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.